Portola Pharmaceuticals is a biopharmaceutical company developing innovative therapeutics that provide significant advances in the treatment of cardiovascular disease and inflammation. Portola’s two most advanced programs are partnered with two of the world’s leading pharmaceutical companies and are in Phase 2 clinical trials.
Learn More
